IL91796A - Pharmacological preparations containing gamma interferon - Google Patents

Pharmacological preparations containing gamma interferon

Info

Publication number
IL91796A
IL91796A IL9179689A IL9179689A IL91796A IL 91796 A IL91796 A IL 91796A IL 9179689 A IL9179689 A IL 9179689A IL 9179689 A IL9179689 A IL 9179689A IL 91796 A IL91796 A IL 91796A
Authority
IL
Israel
Prior art keywords
gamma
interferon
cells
smooth muscle
treatment
Prior art date
Application number
IL9179689A
Other languages
English (en)
Hebrew (he)
Other versions
IL91796A0 (en
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL91796A0 publication Critical patent/IL91796A0/xx
Publication of IL91796A publication Critical patent/IL91796A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
IL9179689A 1988-09-30 1989-09-27 Pharmacological preparations containing gamma interferon IL91796A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803472A SE462364B (sv) 1988-09-30 1988-09-30 Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos

Publications (2)

Publication Number Publication Date
IL91796A0 IL91796A0 (en) 1990-06-10
IL91796A true IL91796A (en) 1994-10-07

Family

ID=20373494

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9179689A IL91796A (en) 1988-09-30 1989-09-27 Pharmacological preparations containing gamma interferon

Country Status (18)

Country Link
US (1) US5208019A (de)
EP (1) EP0367735B1 (de)
JP (1) JP2895896B2 (de)
KR (1) KR0137017B1 (de)
AT (1) ATE86869T1 (de)
AU (1) AU623181B2 (de)
CA (1) CA1338722C (de)
DD (1) DD288094A5 (de)
DE (1) DE68905438T2 (de)
DK (1) DK174523B1 (de)
HU (1) HU206988B (de)
IE (1) IE63874B1 (de)
IL (1) IL91796A (de)
NZ (1) NZ230816A (de)
PH (1) PH26293A (de)
PT (1) PT91863B (de)
SE (1) SE462364B (de)
WO (1) WO1990003189A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP0671954A1 (de) * 1992-02-05 1995-09-20 Thomas Jefferson University Interferon-gentherapie für die behandlung von gefässkrankheiten
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5957972A (en) * 1992-09-29 1999-09-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Implants possessing a surface of endothelial cells genetically-modified to inhibit intimal thickening
PT690726E (pt) * 1993-01-07 2002-05-31 Univ Jefferson Inibicao anti-sentido de c-myc para modular a proliferacao de celulas do musculo liso
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6197789B1 (en) 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
US6323184B1 (en) 1993-10-15 2001-11-27 Thomas Jefferson University Arteriovenous and venous graft treatments: methods and compositions
US6133242A (en) * 1993-10-15 2000-10-17 Thomas Jefferson Univerisity Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US5665591A (en) * 1994-12-06 1997-09-09 Trustees Of Boston University Regulation of smooth muscle cell proliferation
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
CA2210622A1 (en) * 1995-11-17 1997-05-29 Toray Industries, Inc. An agent protecting endothelial cells
US5681558A (en) * 1995-11-30 1997-10-28 Berlex Laboratories, Inc. Method of using beta-interferons to treat restenosis
ES2314786T3 (es) 1998-04-02 2009-03-16 Genentech, Inc. Uso de interferon gamma para el tratamiento de la hipertrofia cardiaca.
US7524826B2 (en) * 2000-04-14 2009-04-28 Mcmaster University And Hamilton Health Sciences Corporation Method of inhibiting the generation of active thrombin on the surface of a cell within an atherosclerotic plaque
AU2002310922A1 (en) * 2001-05-04 2002-11-18 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
JP4896745B2 (ja) 2004-02-02 2012-03-14 アンブレツクス・インコーポレイテツド 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE11014T1 (de) * 1981-07-14 1985-01-15 Efamol Limited Pharmazeutische und diaetetische zusammensetzung zur erhoehung der serie-l-pg-produktion.
US5096705A (en) * 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
US4454115A (en) * 1981-10-23 1984-06-12 Wisconsin Alumni Research Foundation Method of reducing the level of low density lipoproteins in the serum of a patient
US4483849A (en) * 1983-01-07 1984-11-20 Carter William A Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody
US5026544A (en) * 1988-02-16 1991-06-25 Board Of Reagents, The University Of Texas System Methods and compositions for inhibiting the growth of neoplastic cells

Also Published As

Publication number Publication date
SE8803472D0 (sv) 1988-09-30
DE68905438T2 (de) 1993-09-30
HU206988B (en) 1993-03-01
AU623181B2 (en) 1992-05-07
EP0367735B1 (de) 1993-03-17
DE68905438D1 (de) 1993-04-22
JPH04500966A (ja) 1992-02-20
WO1990003189A1 (en) 1990-04-05
ATE86869T1 (de) 1993-04-15
AU4305189A (en) 1990-04-18
PH26293A (en) 1992-04-10
DK56291D0 (da) 1991-03-27
US5208019A (en) 1993-05-04
PT91863B (pt) 1995-05-31
KR0137017B1 (ko) 1998-04-25
JP2895896B2 (ja) 1999-05-24
DD288094A5 (de) 1991-03-21
SE462364B (sv) 1990-06-18
NZ230816A (en) 1997-06-24
HU895542D0 (en) 1991-10-28
PT91863A (pt) 1990-03-30
CA1338722C (en) 1996-11-19
EP0367735A1 (de) 1990-05-09
KR900701308A (ko) 1990-12-01
IL91796A0 (en) 1990-06-10
IE63874B1 (en) 1995-06-14
DK174523B1 (da) 2003-05-12
DK56291A (da) 1991-05-24
HUT57063A (en) 1991-11-28
IE893123L (en) 1990-03-30

Similar Documents

Publication Publication Date Title
EP0367735B1 (de) Verwendung von Interferon-gamma in pharmazeutischen Zubereitungen zur Behandlung von Gefässstenose
Hansson et al. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro.
JP3854307B2 (ja) 細胞外マトリックスの蓄積を防止するためのトランスフォーミング増殖因子βの阻害
EP0979099B1 (de) Verwendung von lactoferrin in der behandlung von beschwerden, die von allergenen verursacht sind
US5318957A (en) Method of stimulating angiogenesis
Konneh et al. Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat
Fiedler et al. Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure
WO1995029694A1 (fr) Accelerateur d'hydrolyse du collegene
Cattaneo et al. Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis
JP3622015B2 (ja) 肺傷害治療剤
EP0408677B1 (de) Steigerung der c1-inhibitorkonzentrationen mittels interferon gamma allein oder in kombination mit interleukin-6
Ruers et al. Immunohistological observations in rat kidney allografts after local steroid administration.
US6060449A (en) Neovascularization inhibitor containing tissue factor pathway inhibitor
CA2100876A1 (en) Anti-growth factor antibodies in the treatment of vascular stenosis
JPH10167982A (ja) 劇症肝炎疾患治療剤
KR100761675B1 (ko) 간 실질세포 증식인자 투여용 제제
AU2005222085B2 (en) Treating or preventing extracellular matrix build-up
WO1997018831A1 (fr) Protection des cellules endotheliales
Boerma et al. Orazipone, a locally acting immunomodulator, ameliorates intestinal radiation injury: a preclinical study in a novel rat model
JPH08295634A (ja) 動脈疾患治療剤
Kadowaki et al. The effect of hypercholesterolemia on early atherosclerotic lesions initiated by fibrinopeptide B
JPH09124506A (ja) 組織因子凝固系インヒビター含有動脈硬化治療剤
JP2688733B2 (ja) 消化管粘膜障害の予防及び治療剤
JPH1025248A (ja) 抗血管リモデリング剤

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired